Marta Pratcorona

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

Elisa Rumi, Daniela Pietra, Cristiana Pascutto et al. · Blood · 2014 · 383 citations · Full text

Medicine, Genetics, Hematology +16

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern

Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters et al. · Blood · 2011 · 335 citations

Medicine, Molecular Biology, Oncology +15

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Marta Pratcorona, Salut Brunet, Josep Nomdedéu et al. · Blood · 2013 · 282 citations

Medicine, Hematology, Oncology +12

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia

Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren et al. · Blood · 2012 · 259 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value

Marta Pratcorona, Sakina Abbas, Matthew A. Sanders et al. · Haematologica · 2011 · 187 citations · Full text

Medicine, Hematology, Oncology +9